Search

[Display omitted] A significant challenge in cancer therapy is to maximize the therapeutic efficacy and minimize the side effects. In the past decade, a lot of nanoparticles have been used as the carriers for efficient drug delivery. This study was to prepare R9 modified with 125I-labeled cRGD and ce6 which self-assembled with miR-139-5p to form nanoparticles (Ce6-R9-125I-RGD-MNPs), and to further take advantage of the enhanced permeability and retention (EPR) effect of radiolabeled nanoparticles to realize the integration of tumor diagnosis and treatment. We successfully synthesized and represented it, saline and serum stability experiments demonstrating good stability. Moreover, Ce6-R9-125I-RGD-MNPs showed superior tumor targeting and the effect of combined photodynamic therapy (PDT) and radiotherapy treatment in vivo and vitro. The pathological results further confirmed that the therapeutic doses of Ce6-R9-125I-RGD-MNPs cause pathological changes of tumor tissues while showing minimal toxicity to normal tissues. [ABSTRACT FROM AUTHOR]

The exploration of sustainable lignocellulosic nanomaterials with unique properties and applicable functions is receiving growing interest. In this work, holocellulose nanofibrils (HCNFs) were prepared from moso bamboo using mild alkaline peroxide bleaching method (MAPB) followed by mechanical nanofibrillation. MAPB was proved to effectively remove lignin and retain hemicellulose. Meanwhile, partial allomorphic changes from cellulose I to cellulose II were revealed together with varying degrees of crystallinity. Thermogravimetric analysis (TGA) experiment showed an increasing thermal stability trend due to more allomorphic changes into anti-parallel cellulose II. Well-dispersed HCNFs suspensions were successfully prepared by homogenization and HCNFs films with high transparency and flexibility were fabricated. The films reached the maximum tensile strength of 55.8 MPa and tensile strain of 1.55 % along with a calculated toughness of 25 MJ/m3. Moreover, the prepared materials are biocompatible and completely non-toxic, which will theoretically support the application of HCNFs materials in fields of biology, medicine and food industry. [Display omitted] [ABSTRACT FROM AUTHOR]

Abstract: Based on gold-labeled silver stain (GLSS) method, we developed the visual protein microarray for simultaneous, sensitive, and specific detection of Ureaplasma parvum and Chlamydia trachomatis using N-terminus multiple-banded antigen (NMBA) of U. parvum and major outer membrane protein of C. trachomatis. The specific antigens were immobilized on glass surface that was treated with 3-glycidoxypropyltrimethoxysilane, and they were used as the capturing probes to recognize the complementary target antibodies binding to the detecting probes of Nano-gold-Staphylococcal protein A (SPA). In the “sandwich” format, Nano-gold-SPA probe was used as an indicator and GLSS was applied to amplify the detection signals and produce black image on array spots, which were visible with naked eyes. In our model arrays, the detection limit of protein microarray was as low as 2 ng/mL, and the lowest titer of detectable antibody was 1:128; thus, this sensitivity was comparable to the fluorescent detection method. The visual simultaneous protein microarrays were used to detect total 186 clinical samples, which had been determined by enzyme-linked immunosorbent assay (ELISA) and fluorescence quantitative real-time polymerase chain reaction; the results were identical and no distinct difference (P > 0.05) existed between them. Our results demonstrate that we have developed the visual protein microarray technique, which is of high sensitivity and high specificity, and it may have potential in clinical applications. [Copyright &y& Elsevier]

Abstract: Evidence has been presented that the species currently known as Ureaplasma urealyticum should be separated into 2 species—Ureaplasma parvum (previously, U. urealyticum biovar 1) and U. urealyticum (previously, U. urealyticum biovar 2). Differentiation and quantification of U. parvum and U. urealyticum can provide important information of the epidemiology of Ureaplasma infections. We developed 2 real-time TaqMan polymerase chain reaction (PCR) assays that would allow rapid, specific, sensitive, quantitative detection and convenient differentiation of U. parvum and U. urealyticum. One hundred twenty-eight clinical specimens were studied and compared with results obtained by culture methods and conventional PCR. The positive rate of real-time TaqMan PCR (59.4%, 76 of 128) was higher than that of culture methods (42.2%, 54 of 128) and conventional PCR (50%, 64 of 128). Of 76 positive specimens, 86.8% (66) contained U. parvum only, 10.5% (8) contained U. urealyticum only, and 2.6% (2) contained both. The copy numbers of 11 positive specimens were in the range of 101 to 103 copies per reaction mixture, 18 in the range of 103 to 105, and 47 in the range of 105 to 108. In the future, quantitative detection and convenient differentiation of real-time TaqMan PCR assays will assist in the study of the pathogenesis and epidemiology of Ureaplasma infections. [Copyright &y& Elsevier]